Frontiers in Medicine

Editorial

Published on 22 May 2017

Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

in Pathology

Umberto Malapelle
Pierlorenzo Pallante

Frontiers in Medicine

doi 10.3389/fmed.2017.00063

2,276 views

Original Research

Published on 24 Apr 2017

Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature

in Pathology

Chiara Saglietti
Marco Volante
Stefano La Rosa
Igor Letovanec
Marc Pusztaszeri
Gaia Gatti
Massimo Bongiovanni

Frontiers in Medicine

doi 10.3389/fmed.2017.00043

5,890 views
14 citations

Review

Published on 05 Apr 2017

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib

in Pathology

Jon Zugazagoitia
Asunción Díaz
Elisabeth Jimenez
Juan Antonio Nuñez
Lara Iglesias
Santiago Ponce-Aix
Luis Paz-Ares

Frontiers in Medicine

doi 10.3389/fmed.2017.00036

7,121 views
11 citations

Original Research

Published on 17 Mar 2017

Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression

in Pathology

Niklas Klümper
Isabella Syring
Wenzel Vogel
Doris Schmidt
Stefan C. Müller
Jörg Ellinger
David Adler
Johannes Brägelmann
Sven Perner

Frontiers in Medicine

doi 10.3389/fmed.2017.00030

4,578 views
17 citations

Perspective

Published on 08 Mar 2017

MAGE-A Antigens and Cancer Immunotherapy

in Pathology

Paul Zajac
Elke Schultz-Thater
Luigi Tornillo
Charlotte Sadowski
Emanuele Trella
Chantal Mengus
Giandomenica Iezzi
Giulio C. Spagnoli

Frontiers in Medicine

doi 10.3389/fmed.2017.00018

22,453 views
73 citations

Perspective

Published on 06 Mar 2017

Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective

in Pathology

Jesús M. Cortés
Giovanni de Petris
José I. López

Frontiers in Medicine

doi 10.3389/fmed.2017.00025

4,216 views
14 citations

Review

Published on 28 Feb 2017

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

in Pathology

Luis Corrales
Amanda Nogueira
Francesco Passiglia
Angela Listi
Christian Caglevic
Marco Giallombardo
Luis Raez
Edgardo Santos
Christian Rolfo

Frontiers in Medicine

doi 10.3389/fmed.2017.00013

20,625 views
17 citations

Review

Published on 23 Feb 2017

Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How

in Pathology

Luca Di Tommaso
Massimo Roncalli

Frontiers in Medicine

doi 10.3389/fmed.2017.00010

9,494 views
26 citations

Mini Review

Published on 13 Feb 2017

Second-Line Treatment of NSCLC—The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms

in Pathology

Jens Köhler

Frontiers in Medicine

doi 10.3389/fmed.2017.00009

6,383 views
13 citations

Review

Published on 23 Jan 2017

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

in Pathology

Chiara Lazzari
Alessandra Bulotta
Monika Ducceschi
Maria Grazia Viganò
Elena Brioschi
Francesca Corti
Luca Gianni
Vanesa Gregorc

Frontiers in Medicine

doi 10.3389/fmed.2017.00004

9,886 views
37 citations

Review

Published on 18 Jan 2017

Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line

in Pathology

Ivana Sullivan
David Planchard

Frontiers in Medicine

doi 10.3389/fmed.2016.00076

33,357 views
109 citations

Mini Review

Published on 23 Dec 2016

Liquid Biopsy in Non-Small Cell Lung Cancer

in Pathology

Miguel A. Molina-Vila
Clara Mayo-de-las-Casas
Ana Giménez-Capitán
Núria Jordana-Ariza
Mónica Garzón
Ariadna Balada
Sergi Villatoro
Cristina Teixidó
Beatriz García-Peláez
Cristina Aguado

Frontiers in Medicine

doi 10.3389/fmed.2016.00069

14,522 views
62 citations

Review

Published on 19 Dec 2016

Focus on Nintedanib in NSCLC and Other Tumors

in Pathology

Anna Manzo
Guido Carillio
Agnese Montanino
Raffaele Costanzo
Claudia Sandomenico
Gaetano Rocco
Alessandro Morabito

Frontiers in Medicine

doi 10.3389/fmed.2016.00068

5,265 views
13 citations

Review

Published on 13 Dec 2016

Focus on Nivolumab in NSCLC

in Pathology

Diego L. Cortinovis
Stefania Canova
Marida Abbate
Francesca Colonese
Paolo Bidoli

Frontiers in Medicine

doi 10.3389/fmed.2016.00067

7,629 views
10 citations

Mini Review

Published on 30 Nov 2016

Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC

in Pathology

Phu N. Tran
Samuel J. Klempner

Frontiers in Medicine

doi 10.3389/fmed.2016.00065

7,667 views
10 citations

Protocols

Published on 21 Nov 2016

Updates on the Methodological Approaches for Carrying Out an In-Depth Study of the Cardiac Conduction System and the Autonomic Nervous System of Victims of Sudden Unexplained Fetal and Infant Death

in Pathology

Graziella Alfonsi
Marina Crippa

Frontiers in Medicine

doi 10.3389/fmed.2016.00054

3,722 views
3 citations